|  | Number (n = 182) | Low-HDLPO group (n = 35) | High-HDLPO group (n = 147) | P value |
---|---|---|---|---|---|
Sex | Male | 158 | 32 | 126 | 0.371a |
 | Female | 24 | 3 | 21 | |
Age | ≤50 | 64 | 13 | 51 | 0.845 |
 | >50 | 118 | 22 | 96 | |
Tumor number | Single | 144 | 27 | 117 | 0.817 |
 | Multiple | 38 | 8 | 30 | |
Tumor size | ≤5 | 115 | 19 | 96 | 0.246 |
 | >5 | 67 | 16 | 51 | |
Tumor encapsulation | None | 112 | 19 | 93 | 0.340 |
 | Complete | 70 | 16 | 54 | |
Satellite lesions | No | 160 | 30 | 130 | 0.663a |
 | Yes | 22 | 5 | 17 | |
Vascular invasion | No | 112 | 19 | 93 | 0.340 |
 | Yes | 70 | 16 | 54 | |
Tumor grade | I-II | 114 | 16 | 98 | 0.032 |
 | III-IV | 68 | 19 | 49 | |
Child-Pugh grade | A | 171 | 31 | 140 | 0.138a |
 | B | 11 | 4 | 7 | |
BCLC stage | 0Â +Â A | 130 | 25 | 105 | 0.575 |
 | B + C | 52 | 10 | 42 | |
AFP,μg/L | ≤400 | 135 | 22 | 113 | 0.131 |
 | >400 | 47 | 13 | 34 | |
ALT,μg/L | ≤40 | 170 | 34 | 136 | 0.278a |
 | >40 | 12 | 1 | 11 | |
GGT,IU/L | ≤54 | 101 | 19 | 82 | 1.000 |
 | >54 | 81 | 16 | 65 |  |
HbsAg | Negative | 23 | 1 | 22 | 0.053a |
 | Positive | 159 | 34 | 125 |  |
Recurrence | No | 97 | 11 | 86 | 0.005 |
 | Yes | 85 | 24 | 61 |  |